Darolutamide and Survival in Metastatic, Hormone-Sensitive Prostate Cancer. Smith MR, Hussain M, Saad F, Fizazi K, et al. N Engl J Med 2022 Feb 17. doi: 10.1056/NEJMoa2119115.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Smith MR, Hussain M, Saad F, Fizazi K, et al. Darolutamide and Survival in Metastatic, Hormone-Sensitive Prostate Cancer. N Engl J Med 2022 Feb 17. doi: 10.1056/NEJMoa2119115.
PMID: 35179323